Results 221 to 230 of about 257,826 (338)

UDP-glycosyltransferases alleviate the toxic effects of deoxynivalenol on the growth performance and gut damage of Kunming mice. [PDF]

Sci Rep
Liu J, Ling X, Chen Z, Yang H, Guo S, Zhou B, Zhu P, Yang Z, Wang Y.   +8 more
europepmc   +1 more source

Role of neutrophils granularity intensity and reactive lymphocytes in assessing changes in lupus activity

Rheumatology &Autoimmunity, EarlyView.
Neut‐GI and Re‐Lymp levels correlated with changes in SLEDAl‐2K scores. Specifically, increasing in SLEDAl‐2K scores was associated with decreasing in extended inflammatory parameters. Thus, Neut‐Gland Re‐Lymp might serve as simpler and more cost‐effective alternatives to SLEDAI‐2K scores for monitoring changes in SLE activity.
Galuh Setyorini, Laniyati Hamijoyo, Evan Susandi, Delita Prihatni, Andri Iskandar Mardia, Amaylia Oehadian   +5 more
wiley   +1 more source

Participation of Cyclophosphamide-Sensitive T Cells in Graft-vs-Host Reactions [PDF]

, 1976
Anthony L. Schwartz, S. Orbach‐Arbouys, Richard K. Gershon   +2 more
openalex   +1 more source

Rituximab in systemic sclerosis-associated interstitial lung disease: A systematic review and meta-analysis. [PDF]

Sci Prog
Jang JH, Her M, Oh JH, Park JH, Jung SY, Ko J, Lee JH.   +6 more
europepmc   +1 more source

Predictors of systemic sclerosis patients with interstitial lung disease progression: A retrospective study

Rheumatology &Autoimmunity, EarlyView.
The final systemic sclerosis patients with interstitial lung disease (SSc‐ILD) progression prediction model was composed of 6 significant risk factors: male, type 2 diabetes mellitus, pericardial effusion, anti‐Ro52, hypoproteinemia, and elevated C‐reactive protein. Our model demonstrated excellent prognostic utility.
Xi Cao, Shanshan Wang, Wenyi Yuan, Mian Liu, Xiaoyan Xin, Xiang Fang, Dandan Wang   +6 more
wiley   +1 more source

Cyclophosphamide therapy in prepubertal rats and subsequent reproductive performance [PDF]

, 1971
C. L. Berry
openalex   +1 more source

A high-efficiency automatic pressure-relief drug transfer device for anticancer medications with superior closed performance. [PDF]

Front Pharmacol
Xie L, Chen G, Ouyang Q, Quan W, Xie X, Chen X, Li L, Li S, Chen R, Luo R, Qiu Z.   +10 more
europepmc   +1 more source

Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape

Small, EarlyView.
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai, Dhwani Rana, Mitali Patel, Neha Bajwa, Rajendra Prasad, Lalitkumar K. Vora   +5 more
wiley   +1 more source

Effect of cyclophosphamide on the response of chickens to a virulent strain of Marek's disease virus [PDF]

, 1975
Vali Kermani-Arab, Thomas Moll, B R Cho, William C. Davis, Yuying Lu   +4 more
openalex   +1 more source

Dermal cellular senescence and EndMT in patients with systemic sclerosis undergoing cyclophosphamide or aHSCT treatment. [PDF]

Rheumatology (Oxford)
Chiu YH, van Dijk M, Goldschmeding R, van Laar JM, de Vries-Bouwstra JK, Spierings J.   +5 more
europepmc   +1 more source